Vestnik dermatologii i venerologiiVestnik dermatologii i venerologii0042-46092313-6294Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov61010.25208/vdv610Research ArticlePityriasis rubra pilaris with the concomitant Leser — Trelat syndromeButarevaM Mnastasya_66@mail.ruZnamenskayaL F-BezyayevaYu S-KappushevaI A-State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation15062013893647111032020Copyright © 2013, Butareva M.M., Znamenskaya L.F., Bezyayeva Y.S., Kappusheva I.A.2013The authors describe a rare case of pityriasis rubra pilaris with the concomitant Leser — Trelat syndrome. Taking into consideration contra-indications for UV therapy, Neotigason (acitretin) was prescribed in the dose of 25 mg a day. Nearly absolute regression of eruptions characteristic of pityriasis rubra pilaris and multiple seborrheic keratomas was observed.hyperkeratosis follicularispityriasis rubra pilarisLeser — Trelat syndromeNeotigasonфолликулярный кератозпитириаз красный волосяной отрубевидныйсиндром Лезера — Треланеотигазон[Griffiths W.A. Pityriasis rubra pilaris. Clin Exp Dermatol 1980; 5: 1: 105, 112.][Besnier E. Observations pour servir à l’histoire clinique du pityriasis rubra pilaire. Ann Dermatol Syphiligr (Paris) 1889; 10(ser 2): 253—287.][Griffiths W.A. Pityriasis rubra pilaris: the problem of its classification. J Am Acad Dermatol 1992; 26: 1: 140—142.][Allison D.S., El-Azhary R.A., Calobrisi S.D., Dicken C.H. Pityriasis rubra pilaris in children. J Am Acad Dermatol 2002; 47: 3: 386—389.][Галлямова Ю.А. Клинические проявления красного волосяного лишая Девержи. Эксперим и клин дерматокосметол 2006; 5: 47—51.][Allison D.S., El-Azhary R.A., Calobrisi S.D., Dicken C.H. Pityriasis rubra pilaris in children. J Am Acad Dermatol 2002; 47: 3: 386—389.][Sehgal V.N., Srivastava G. (Juvenile) Pityriasis rubra pilaris. Int J Dermatol 2006; 45: 4: 438—446.][Vanderhooft S.L., Francis J.S., Holbrook K.A. et al. Familial pityriasis rubra pilaris. Arch Dermatol 1995; 131: 4: 448—453.][Loewenthal L.J. A new cutaneous manifestation in the syndrome of vitamin A deficiency. Arch Dermatol Syphilol 1933; 28: 700—708.][Finch S., Doyle W., Lowe C., Bates C.J., Prentice A., Smithers G., Clarke P.C. Nutritional diet and nutrition survey. The Staionary Office 1998: London UK.][Вавилов А.М., Катунина О.Р., Мордовцев В.Н. Иммуноморфологическая характеристика клеток воспалительного инфильтрата в коже больных красным волосяным лишаем Девержи. Вестн дерматол венерол 2006; 4: 4—7.][Куклин В.Т., Куклина З.В., Никифоров А.П. и др. К патогенезу красного отрубевидного волосяного лишая Девержи. Рос журн кож вен бол 2002; 1: 18—21.][Mohrenschlager M., Abeck D. Further clinical evidence for involvement of bacterial superantigens in juvenile pityriasis rubra pilaris (PRP): report of two cases. Pediatr Dermatol 2002; 19: 569.][Artik S., Kuhn A., Neumann N.J., Ruzicka T., Megahed M: Pityriasis rubra pilaris. Hautarzt 2004; 55: 980—983.][Kawara S., Miyake M., Oiso N., Kawada A. Pityriasis rubra pilaris with preceding cytomegalovirus infection. Dermatology 2009; 219: 350—352.][Reinhardt L.A., Rosen T. Pityriasis rubra pilaris as the initial manifestation of leukemia. Cutis 1983; 31: 100—102.][Griffiths W.A. Pityriasis rubra pilaris — an historical approach. 2. Clinical features. Clin Exp Dermatol 1976; 1: 1: 37—50.][Martinez Calixto L.E., Suresh L., Matsumura E. et al. Oral pityriasis rubra pilaris. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101; 5: 604—607.][Сафонова А.В. Острый вариант болезни Девержи у взрослого. Рос журн кож вен бол 1999; 5: 59—60.][Burger B., Spoerri I., Schubert M., Has C., Itin P.H. Description of the natural course and clinical manifestations of ichthyosis with confetti caused by a novel KRT10 mutation. Br J Dermatol 2011; 166: 434—439.][Miralles E.S., Nunez M., De Las Heras M.E., Pérez B., Moreno R., Ledo A. Pityriasis rubra pilaris and human immunodeficiency virus infection. Br J Dermatol 1995; 133: 990—993.][Borok M., Lowe N.J. Pityriasis rubra pilaris. Further observations of systemic retinoid therapy. J Am Acad Dermatol 1990; 22: 5 (Pt 1): 792—795.][Clayton B.D., Jorizzo J.L., Hitchcock M.G. et al. Adult pityriasis rubra pilaris: a 10-year case series. J Am Acad Dermatol 1997; 36: (6 Pt 1): 959—964.][Albert M.R., Mackool B.T. Pityriasis rubra pilaris. Int J Dermatol 1999; 38: 1—11.][Müller H., Gattringer C., Zelger B., Höpfl R., Eisendle K. Infliximab monotherapy as firstline treatment for adultonset pityriasis rubra pilaris: case report and review of the literature on biologic therapy. J Am Acad Dermatol 2008; 59 (suppl): 65—70.][Drosou A., Kirsner R.S., Welsh E., Sullivan T.P., Kerdel F.A. Use of infliximab, an anti-tumor necrosis factor alpha antibody, for inflammatory dermatoses. J Cutan Med Surg 2003; 7: 382—386.][Manoharan S., White S., Gumparthy K. Successful treatment of type I adult-onset pityriasis rubra pilaris with infliximab. Australas J Dermatol 2006; 47: 124—129.][Ruiz-Genao D.P., Lopez-Estebaranz J.L., Naz-Villalba E., Gamo-Villegas R., Calzado-Villarreal L., Pinedo-Moraleda F. Pityriasis rubra pilaris successfully treated with infliximab. Acta Derm Venereol 2007; 87: 552—553.][Liao W.C., Mutasim D.F. Infliximab for the treatment of adult-onset pityriasis rubra pilaris. Arch Dermatol 2005; 141: 423—425.][Lu R., George S.J., Hsu S. Pityriasis rubra pilaris: failure of combination treatment with acitretin and infliximab. Dermatol Online J 2006; 30: 12—18.][Garcovich S., Di Giampetruzzi A.R., Antonelli G., Garcovich A., Didona B. Treatment of refractory adult-onset pityriasis rubra pilaris with TNF-alpha antagonists: a case series. J Eur Acad Dermatol Venereol 2010; 24: 881—884.][Klein A., Szeimies R.M., Landthaler M., Karrer S. Exacerbation of pityriasis rubra pilaris under efalizumab therapy. Dermatology 2007; 215: 72—75.][Davis K.F., Wu J.J., Murase J.E., Rosenberg F.R., Sorenson E.P., Meshkinpour A. Clinical improvement of pityriasis rubra pilaris with combination etanercept and acitretin therapy. Arch Dermatol 2007; 143: 1597—1599.][Walling H.W., Swick B.L. Pityriasis rubra pilaris responding rapidly to adalimumab. Arch Dermatol 2009; 145: 99—101.][Schreml S., Zeller V., Babilas P., Karrer S., Landthaler M., Szeimies R.M. Pityriasis rubra pilaris successfully treated with adalimumab. Clin Exp Dermatol 2010; 35: 792—793.][Guedes R., Leite L. Therapeutic hotline. Treatment of pityriasis rubra pilaris with etanercept. Dermatol Ther 2011; 24: 285—286.][Vasher M., Smithberger E., Lien M.H., Fenske N.A. Familial pityriasis rubra pilaris: report of a family and therapeutic response to etanercept. J Drugs Dermatol 2010; 9: 844—850.][Zhang Y.H., Zhou Y., Ball N., Su M.W., Xu J.H., Zheng Z.Z. Type I pityriasis rubra pilaris: upregulation of tumor necrosis factor alpha and response to adalimumab therapy. J Cutan Med Surg 2010; 14: 185—188.]